🇺🇸 FDA
Patent

US 8183014

High affinity antibodies to human IL-6 receptor

granted A61KA61K2039/505A61P

Quick answer

US patent 8183014 (High affinity antibodies to human IL-6 receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/505, A61P, A61P1/00, A61P1/04